Antibacterial protein 2

Soy protein isolate (SPI) is green, high-yield natural plant protein, which is widely applied in industry (packing material and adhesives) and tissue engineering. It is meaningful to improve the antibacterial property of soy protein isolate to fabricate versatile safe products to meet people's requirements. In this study, quaternized soy protein isolate (QSPI) was synthesized by the reaction between 2,3-epoxypropyltrimethylammonium chloride (EPTMAC) and SPI. The positive charged (17.8 ± 0.23 mV) quaternary ammonium groups endow the QSPI with superior antibacterial properties against multiple bacteria in vitro and in vivo. Notably, QSPI maintains its good biocompatibility and promotes bacterial-infected wound healing in rat models. Furthermore, QSPI possesses superior water solubility in a broad pH range than raw SPI. Altogether, this soy protein isolate derivative with antibacterial property and superior water solubility may extend the application of SPI in industry and tissue engineering.

Low serum albumin levels are very common in critically ill patients, with reported incidences as high as 40-50%. This condition appears to be associated with alterations in the degree of protein binding of many highly protein-bound antibacterials, which lead to altered pharmacokinetics and pharmacodynamics, although this topic is infrequently considered in daily clinical practice. The effects of hypoalbuminaemia on pharmacokinetics are driven by the decrease in the extent of antibacterial bound to albumin, which increases the unbound fraction of the drug. Unlike the fraction bound to plasma proteins, the unbound fraction is the only fraction available for distribution and clearance from the plasma (central compartment). Hence, hypoalbuminaemia is likely to increase the apparent total volume of distribution (V(d)) and clearance (CL) of a drug, which would translate to lower antibacterial exposures that might compromise the attainment of pharmacodynamic targets, especially for time-dependent antibacterials.

Considering the biocompatibility of natural proteins and the strong photo-redox capability of Z-scheme heterojunctions, we fabricated Z-scheme ZnIn2S4/Ag2MoO4@Zein (Z ZA) photocatalytic membranes via electrospinning and in-situ precipitation for enrofloxacin (ENR) degradation. Z ZA exhibit a fiber structure wrapped with ZnIn2S4/Ag2MoO4 heterojunctions. Photocatalytic studies and various characterization results certified that the Z-scheme structure between ZnIn2S4 and Ag2MoO4 significantly increases the lifetime and separation efficiency of photogenerated carriers, which in turn enhances the photodegradation of ENR. The degradation rate of Z ZA-10 (ZnIn2S4/10 wt% Ag2MoO4@Zein) with the highest catalytic activity could reach 100% within 120 min compared with other samples. For ENR degradation, ·O2- radicals were certified to be the primary active species by trapping experiments, and several possible conversion pathways of ENR in photocatalytic reactions were proposed. Furthermore, the antibacterial rates of Z ZA-20 (ZnIn2S4/20 wt% Ag2MoO4@Zein) against B. subtilis, P. aeruginosa, S. aureus, and E. coli could reach 90.09%, 89.78%, 84.34%, and 95.31%, respectively. Antibacterial evaluations and cytotoxicity assays demonstrated that Z ZA photocatalytic films had desirable antibacterial properties and low cytotoxicity, rendering them safe and effective for use in the treatment of antibiotic wastewater.